1,178
Participants
Start Date
November 4, 2024
Primary Completion Date
January 28, 2025
Study Completion Date
June 24, 2025
High-Dose trivalent influenza vaccine (Split virion, Inactivated)
Liquid suspension for intramuscular injection
Standard-dose trivalent influenza vaccine (Split virion, Inactivated)
Liquid suspension for intramuscular injection
CBH Health - Gaithersburg- Site Number : 8400004, Gaithersburg
Centricity Morehead- Site Number : 8400014, Morehead City
Centricity New Bern- Site Number : 8400015, New Bern
Cenexel IRA - iResearch Atlanta- Site Number : 8400007, Decatur
The Hope Clinic of Emory Vaccine Center- Site Number : 8400017, Decatur
Cenexel IRS - iResearch Savannah- Site Number : 8400008, Savannah
Centricity Research - Rincon- Site Number : 8400012, Rincon
IACT Health - Columbus - Talbotton Road- Site Number : 8400011, Columbus
Research Centers of America - Hollywood- Site Number : 8400010, Hollywood
Alliance for Multispeciality Research - Fort Myers- Site Number : 8400019, Fort Myers
Alliance for Multispecialty Research - Volunteer Research Group- Site Number : 8400001, Knoxville
Alliance for Multispeciality Research - Lexington- Site Number : 8400002, Lexington
Aventiv Research Columbus- Site Number : 8400016, Columbus
Alliance for Multispeciality Research - Newton- Site Number : 8400003, Newton
JBR Clinical Research- Site Number : 8400009, Salt Lake City
CenExel CNS- Site Number : 8400005, Los Alamitos
Kaiser Permanente Center for Health Research- Site Number : 8400018, Portland
Kaiser Permanente Washington- Site Number : 8400024, Seattle
Hassman Research Institute - Berlin- Site Number : 8400006, Berlin
Centricity Research - Suffolk Primary Care - Centricity - PPDS- Site Number : 8400013, Suffolk
Sanofi Pasteur, a Sanofi Company
INDUSTRY